IDROSSICLOROCHINA AUMENTA LA MORTALITA’ PER COVID-19: UNA META-ANALISI COLLABORATIVA DA “NATURE COMMUNICATIONS”
Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials Cathrine Axfors, Andreas M. Schmitt. Substantial COVID-19 research investment has been allocated to randomized clinical trials (RCTs) on hydroxychloroquine/chloroquine, which currently face recruitment challenges or early discontinuation. We aim to estimate the effects of hydroxychloroquine and chloroquine on survival…